Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.03 | -$0.02 | -$0.02 |
| Q2 2026 | 2 | -$0.03 | -$0.01 | -$0.02 |
| Q3 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2026 | 1 | $0.01 | $0.01 | $0.01 |
Precigen Inc last posted its earnings results on Wednesday, March 25th, 2026. The company reported $-0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.09. The company had revenue of 4.57 M for the quarter and had revenue of 9.68 M for the year. Precigen Inc has generated $-1 earnings per share over the last year ($-1.41 diluted earnings per share) and currently has a price-to-earnings ratio of -5.46. Precigen Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/25/2026 | Q4 2025 | -$0.10 | -$0.07 | 0.03 | $8.42 M | $4.57 M |
| 11/13/2025 | Q3 2025 | -$0.08 | -$1.10 | -1.02 | $500.00 K | $2.92 M |
| 08/12/2025 | Q2 2025 | -$0.14 | -$0.09 | 0.05 | $952.00 K | $856.00 K |
| 05/14/2025 | Q1 2025 | -$0.08 | -$0.18 | -0.1 | $650.00 K | $1.34 M |
| 03/19/2025 | Q4 2024 | -$0.06 | -$0.07 | -0.01 | $3.03 M | $1.19 M |
| 11/14/2024 | Q3 2024 | -$0.08 | -$0.09 | -0.01 | $931.40 K | $953.00 K |
| 08/14/2024 | Q2 2024 | -$0.09 | -$0.23 | -0.14 | $1.29 M | $717.00 K |
| 03/29/2024 | Q1 2024 | N/A | -$0.10 | N/A | $1.48 M | $1.07 M |
| 12/29/2023 | Q4 2023 | N/A | -$0.13 | N/A | N/A | $1.23 M |
| 11/09/2023 | Q3 2023 | -$0.08 | -$0.08 | 0 | N/A | $1.38 M |
| 08/09/2023 | Q2 2023 | -$0.10 | -$0.08 | 0.02 | N/A | $1.77 M |
| 05/10/2023 | Q1 2023 | -$0.08 | -$0.10 | -0.02 | N/A | $1.85 M |
| 03/06/2023 | Q4 2022 | -$0.10 | -$0.11 | -0.01 | N/A | $1.76 M |
| 11/09/2022 | Q3 2022 | $0.10 | $0.44 | 0.34 | N/A | $16.72 M |
| 08/08/2022 | Q2 2022 | -$0.16 | -$0.13 | 0.03 | N/A | $2.91 M |
| 05/09/2022 | Q1 2022 | -$0.14 | -$0.10 | 0.04 | N/A | $5.51 M |
| 03/01/2022 | Q4 2021 | -$0.14 | -$0.13 | 0.01 | N/A | $3.68 M |
| 11/08/2021 | Q3 2021 | -$0.14 | -$0.15 | -0.01 | N/A | $3.33 M |
| 08/09/2021 | Q2 2021 | -$0.12 | -$0.10 | 0.02 | N/A | $3.82 M |
| 05/10/2021 | Q1 2021 | -$0.16 | -$0.09 | 0.07 | N/A | $3.44 M |
In the previous quarter, Precigen Inc (:PGEN) reported $-0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.09.
The conference call for Precigen Inc's latest earnings report can be listened to online.
The conference call transcript for Precigen Inc's latest earnings report can be read online.
Precigen Inc (:PGEN) has a recorded annual revenue of $9.68 M.
Precigen Inc (:PGEN) has a recorded net income of $-250,642,000.Precigen Inc has generated $-1.41 earnings per share over the last four quarters.
Precigen Inc (:PGEN) has a price-to-earnings ratio of -5.46 and price/earnings-to-growth ratio is 0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED